BridgeMD
New treatment option for Parkinson Disease
Official title Light Therapy in Parkinson's Disease
ClinicalTrials.gov ID: NCT06129942
What this study is testing
- What it's testing
- The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were...
- All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs...
You likely can't join if
- Using hypnotic or stimulating drugs.
- Using antidepressants, except stable drugs maintained for more than three months;
- Visual impairment, such as cataract, glaucoma, blindness, etc;
- Cognitive impairment (MMSE \< 24);
- There are uncontrollable hallucinations and mental diseases;
- There are sleep phase delay / advance syndrome, shift work, jet lag, etc
The study team makes the final eligibility decision.
Where it's taking place
- Suzhou, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suzhou, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.